Skip to main content
OpenTrials

Clinical trial condition

Head and Neck Squamous Cell Carcinoma

Explore clinical trials studying Head and Neck Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.

364 public trials 121 recruiting studies
Refine in advanced search Browse all conditions

Head and Neck Squamous Cell Carcinoma trial results

Recruiting

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

NCT03556228

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Adenoma, +65 more
Locations
  • Providence Medical Foundation (site 209) Santa Rosa, California, United States
  • Hartford Hospital (site 210) Hartford, Connecticut, United States
  • The George Washington University Cancer Center (site 212) Washington D.C., District of Columbia, United States
  • Holy Cross Hospital (site 213) Fort Lauderdale, Florida, United States
View all 15 locations
View Trial Details
Recruiting

Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)

NCT06088381

Conditions
Carcinoma, Carcinoma, Squamous Cell, HPV Positive Oropharyngeal Squamous Cell Carcinoma, +16 more
Locations
  • Maryland Proton Treatment Center Baltimore, Maryland, United States
  • University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States
  • Upper Chesapeake Health Bel Air, Maryland, United States
  • Central Maryland Radiation Oncology Columbia, Maryland, United States
View Trial Details
Recruiting

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

NCT05902988

Conditions
Advanced Solid Tumor, Breast Diseases, Breast Neoplasms, +34 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Hoag Memorial Hospital Newport Beach, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 14 locations
View Trial Details
Recruiting

A Study of NX-1607 in Adults With Advanced Malignancies

NCT05107674

Conditions
Adenoma, Adnexal Diseases, Breast Diseases, +75 more
Locations
  • City of Hope Duarte, California, United States
  • University of Southern California Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • University of Colorado School of Medicine Aurora, Colorado, United States
View all 17 locations
View Trial Details
Recruiting

Pembrolizumab in Combination With Low-dose PFas Neoadjuvant Treatment for Locally Advanced HNSCC

NCT05446467

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • The Affiliated Hospital of Qingdao University Qingdao, Shandong, China
  • Zhejiang Provincial People's Hospital Hangzhou, Zhejiang, China
  • Sir Run Run Shaw Hospital School of Medicine,Zhejiang University Hangzhou, China
  • Zhejiang Cancer Hospital Hangzhou, China
View Trial Details
Recruiting

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

NCT04429542

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +39 more
Locations
  • Moores Cancer Center UC San Diego Health La Jolla, California, United States
  • Keck School of Medicine of USC Los Angeles, California, United States
  • UCLA Los Angeles, California, United States
  • University of California, Davis Comprehensive Cancer Center Sacramento, California, United States
View all 20 locations
View Trial Details

Related conditions